| 1 Executive Summary |
| 2 Introduction |
| 2.1 Key Highlights of the Report |
| 2.2 Report Description |
| 2.3 Market Scope & Segmentation |
| 2.4 Research Methodology |
| 2.5 Assumptions |
| 3 Antigua and Barbuda COVID-19 Saliva Screening Test Potential Market Overview |
| 3.1 Antigua and Barbuda Country Macro Economic Indicators |
| 3.2 Antigua and Barbuda COVID-19 Saliva Screening Test Potential Market Revenues & Volume, 2021 & 2031F |
| 3.3 Antigua and Barbuda COVID-19 Saliva Screening Test Potential Market - Industry Life Cycle |
| 3.4 Antigua and Barbuda COVID-19 Saliva Screening Test Potential Market - Porter's Five Forces |
| 3.5 Antigua and Barbuda COVID-19 Saliva Screening Test Potential Market Revenues & Volume Share, By Location, 2021 & 2031F |
| 3.6 Antigua and Barbuda COVID-19 Saliva Screening Test Potential Market Revenues & Volume Share, By Technology, 2021 & 2031F |
| 3.7 Antigua and Barbuda COVID-19 Saliva Screening Test Potential Market Revenues & Volume Share, By Mode, 2021 & 2031F |
| 4 Antigua and Barbuda COVID-19 Saliva Screening Test Potential Market Dynamics |
| 4.1 Impact Analysis |
| 4.2 Market Drivers |
|
4.2.1 Increasing awareness and importance of early detection of COVID-19 in Antigua and Barbuda |
|
4.2.2 Government initiatives to promote and facilitate widespread testing |
|
4.2.3 Growing demand for non-invasive and easily accessible testing options |
| 4.2.1 Growing need for non-invasive testing methods |
| 4.2.2 Government focus on pandemic readiness and rapid testing infrastructure |
| 4.2.3 Increasing demand for point-of-care diagnostics |
| 4.2.4 Advancements in saliva-based testing technologies |
| 4.2.5 Rising testing requirements at mass gathering venues (sports, travel, etc.) |
| 4.3 Market Restraints |
|
4.3.1 Limited healthcare infrastructure and resources in Antigua and Barbuda |
|
4.3.2 Regulatory challenges and approvals for new testing methods |
|
4.3.3 Public skepticism or lack of trust in the accuracy of saliva screening tests |
| 4.3.1 Limited infrastructure in remote locations |
| 4.3.2 Potential for false negatives/positives in early detection |
| 4.3.3 Regulatory delays for new technologies |
| 4.3.4 Public reluctance toward frequent testing |
| 4.3.5 High initial investment for decentralized testing setups |
| 4.4 Market Key Performance Indicators (KPI) |
|
44.1 Percentage increase in the number of individuals opting for COVID-19 saliva screening tests |
|
44.2 Rate of adoption of saliva screening tests in healthcare facilities and community testing centers |
|
44.3 Average turnaround time for test results to be delivered to individuals |
|
44.4 Percentage of positive cases detected through saliva screening tests |
|
44.5 Level of satisfaction among healthcare professionals and individuals using saliva screening tests |
| 4.4.1 Testing accuracy rate (%) |
| 4.4.2 Detection window effectiveness (days) |
| 4.4.3 Number of decentralized test units deployed |
| 4.4.4 Test turnaround time (minutes) |
| 4.4.5 Cost per test (USD) |
| 5 Antigua and Barbuda COVID-19 Saliva Screening Test Potential Market Trends |
| 6 Antigua and Barbuda COVID-19 Saliva Screening Test Potential Market, By Types |
| 6.1 Antigua and Barbuda COVID-19 Saliva Screening Test Potential Market, By Location |
| 6.1.1 Overview and Analysis |
| 6.1.2 Antigua and Barbuda COVID-19 Saliva Screening Test Potential Market Revenues & Volume, By Location, 2021–2031F |
| 6.1.3 By Travel Stations |
| 6.1.4 By Sports Arenas |
| 6.1.5 By Entertainment Venues |
| 6.1.6 By Corporate Campus Environments |
| 6.1.7 By Universities & Colleges |
| 6.1.8 By Factories |
| 6.2 Antigua and Barbuda COVID-19 Saliva Screening Test Potential Market, By Technology |
| 6.2.1 Overview and Analysis |
| 6.2.2 By Fluorescence-labeled Antigen/Antibodies Testing |
| 6.2.3 By RT-PCR |
| 6.2.4 By CRISPR-Cas9 |
| 6.3 Antigua and Barbuda COVID-19 Saliva Screening Test Potential Market, By Mode |
| 6.3.1 Overview and Analysis |
| 6.3.2 By Centralized Testing |
| 6.3.3 By Decentralized Testing |
| 7 Antigua and Barbuda COVID-19 Saliva Screening Test Potential Market Import-Export Trade Statistics |
| 7.1 Export to Major Countries |
| 7.2 Import from Major Countries |
| 8 Antigua and Barbuda COVID-19 Saliva Screening Test Potential Market Key Performance Indicators |
| 9 Antigua and Barbuda COVID-19 Saliva Screening Test Potential Market - Opportunity Assessment |
| 9.1 Opportunity Assessment, By Location |
| 9.2 Opportunity Assessment, By Technology |
| 9.3 Opportunity Assessment, By Mode |
| 10 Antigua and Barbuda COVID-19 Saliva Screening Test Potential Market - Competitive Landscape |
| 10.1 Market Revenue Share, By Companies, 2024 |
| 10.2 Competitive Benchmarking, By Operating and Technical Parameters |
| 11 Company Profiles |
| 12 Recommendations |
| 13 Disclaimer |